To elucidate which of these pathways are up‐regulated in NAFL, we measured hepatic mRNA levels for Lpcat2, cPla2, Alox15 (15‐LOX), Alox5 (5‐LOX), and Alox12 (12‐LOX) in WT‐RCD control mice and the three corresponding NAFL groups. The gene discussed is ALOX12; the disease is non-alcoholic fatty liver.